BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease (BENEFIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00123916
Recruitment Status : Unknown
Verified June 2005 by Population Health Research Institute.
Recruitment status was:  Recruiting
First Posted : July 26, 2005
Last Update Posted : August 3, 2011
Canadian Institutes of Health Research (CIHR)
World Health Organization
Instituto Dante Pazzanese de Cardiologia
University of Sao Paulo
Information provided by:
Population Health Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2013
  Estimated Study Completion Date : July 2013
Publications automatically indexed to this study by Identifier (NCT Number):